Cormorant Global Healthcare Master Fund, LP, 10% Owner at Immuneering Corp (IMRX), sold 1,418,182 shares at $5.97 ($4.6M) on 2024-03-14, disclosed to the SEC on 2024-03-18.
Open-market sale of $4.6M IMRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.24 | 345,266 | $1.1M | 24.1% |
| 2 | $3.24 | 345,266 | $1.1M | 24.1% |
| 3 | $4.25 | 98,570 | $419K | 9.0% |
| 4 | $4.25 | 98,570 | $419K | 9.0% |
| 5 | $5.37 | 54,215 | $291K | 6.3% |
| 6 | $5.37 | 54,215 |
| $291K |
| 6.3% |
| 7 | $5.97 | 11,040 | $66K | 1.4% |
| 8 | $5.97 | 11,040 | $66K | 1.4% |
| 9 | $2.14 | 400,000 | $856K | 18.4% |
| Total | $3.28 avg | 1,418,182 | $4.6M | 100% |
| Filing → |
| DRUG | BUY | 2024-10-17 | $6.4M | — | Filing → |
| CRBP | BUY | 2024-09-24 | $14.0M | — | Filing → |
| EYPT | BUY | 2024-04-22 | $21.0M | — | Filing → |